drugset / Trial / NCT03770052
Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
Phase 4
Completed
159 enrolled
Pusan National University Hospital
Chong Kun Dang Pharmaceutical · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
Timeline
- Start
- 2018-10-24
- Primary completion
- 2021-08-19
- Completion
- 2021-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeglitazone | Small molecule | 0.25 mg | — |
| Subject | Lobeglitazone | Small molecule | 0.5 mg | — |